Physician profile
Kaleb Douglas Lambeth
NPI 1679061550
$19,822.66
in general payments reported to CMS, 2019-2025
39 companies · $8,545 in 2025
The $8,545 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $1,121 · 2023: $2,969 · 2024: $6,970 · 2025: $8,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,273 · Grant: $4,500 · Travel and Lodging: $3,797 · Education: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,272.81 |
| Grant | $4,500.00 |
| Travel and Lodging | $3,797.07 |
| Education | $913.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,435.10 | 2022-2025 | Micra, Cobalt Dr Mri Surescan, Corevalve Evolut R |
| Biosense Webster, INC. | $3,590.71 | 2023-2025 | Carto 3, Nuvision Ice Catheter, Visitag Surpoint External Processing Unit |
| Boston Scientific Corporation | $3,152.69 | 2022-2025 | Farapulse, Watchman Flx, Emblem Mri S-Icd |
| Medical Device Business Services, INC. | $947.70 | 2023-2024 | Carto 3 |
| Abbott Laboratories | $833.66 | 2023-2025 | Cardiomems, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Sanofi-Aventis U.S. LLC | $540.83 | 2022-2023 | |
| Pfizer INC. | $533.22 | 2021-2024 | |
| Inari Medical, INC. | $352.28 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Actelion Pharmaceuticals US, INC. | $292.97 | 2023-2025 | Opsumit, Uptravi |
| Amgen INC. | $249.01 | 2022-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $187.36 | 2023-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $171.96 | 2023-2024 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $171.48 | 2023-2025 | |
| Cardiva Medical, INC. | $155.29 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Livanova USA, INC. | $151.69 | 2023 | Tandemheart |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $142.77 | 2022 | |
| Bridgebio Pharma, INC. | $140.34 | 2025 | Attruby |
| Atricure, INC. | $127.71 | 2024 | |
| Edwards Lifesciences Corporation | $102.54 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $65.18 | 2022-2025 | |
| Kiniksa Pharmaceuticals, Ltd. | $40.95 | 2023 | Arcalyst |
| Shockwave Medical, INC | $36.90 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $36.13 | 2023 | Gore Cardioform Septal Occluder |
| Chiesi USA, INC. | $33.00 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $32.56 | 2024 | Arcalyst |
| Cvrx, INC. | $28.79 | 2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.59 | 2024 | Jardiance |
| Abiomed | $25.70 | 2025 | |
| Baxter Healthcare | $24.83 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Cordis US Corp. | $24.37 | 2023 | Outback Elite |
| Esperion Therapeutics, INC. | $23.76 | 2025 | Nexletol |
| Astellas Pharma US INC | $21.62 | 2021 | |
| Bard Peripheral Vascular, INC. | $21.14 | 2023 | Lutonix Drug Coated Balloon |
| Medline Industries Lp | $18.94 | 2024 | Medline Industries, INC. |
| Contego Medical, INC | $18.50 | 2024 | |
| Merck Sharp & Dohme LLC | $17.72 | 2024 | Verquvo |
| Heartflow, INC. | $17.12 | 2024 | |
| Janssen Pharmaceuticals, INC | $15.51 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $14.04 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaleb Lambeth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.